Os07g0183200 Antibody

What is Os07g0183200 Antibody and what are its key specifications?

Os07g0183200 Antibody (product code CSB-PA808449XA01OFG) is a polyclonal antibody raised in rabbits against recombinant Oryza sativa subsp. japonica (Rice) Os07g0183200 protein. It is an IgG isotype antibody that has been antigen-affinity purified and is supplied in liquid form. The antibody is specific to Oryza sativa subsp. japonica and has been validated for ELISA and Western Blot applications. The UniProt accession number for the target protein is Q8H507 .

The antibody's comprehensive specifications include:

What are the optimal storage and handling conditions for Os07g0183200 Antibody?

For optimal antibody stability and functionality, store Os07g0183200 Antibody at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of antibody activity . The antibody is supplied in a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4, which helps maintain stability during storage .

For working solutions, aliquot the antibody into smaller volumes based on experimental needs before freezing to minimize freeze-thaw cycles. When handling the antibody, use sterile techniques and maintain cold chain conditions to preserve activity. Document all freeze-thaw events and monitor antibody performance over time to track potential activity loss.

How should Os07g0183200 Antibody be validated before experimental use?

Proper antibody validation is critical for ensuring reproducible research results, particularly given the widespread concerns about antibody specificity in the scientific community . For Os07g0183200 Antibody, validation should include:

• Positive Control Testing: Use recombinant Os07g0183200 protein or rice tissue samples known to express the target protein.

• Negative Control Testing: Include samples from knockout lines or species not expected to express cross-reactive proteins.

• Specificity Verification: Perform pre-adsorption tests with the immunizing antigen to confirm signal abrogation.

• Application-Specific Validation: For each application (ELISA, WB), perform titration experiments to determine optimal antibody concentration.

• Lot-to-Lot Verification: When receiving a new lot, compare performance against previous lots using standardized samples.

This comprehensive validation approach aligns with recommendations to address the "antibody characterization crisis" in biomedical research and ensures experimental reproducibility .

How can computational approaches like RosettaAntibodyDesign (RAbD) complement experimental use of Os07g0183200 Antibody?

RosettaAntibodyDesign (RAbD) represents a structural-bioinformatics-based computational framework that can be leveraged to optimize antibody design and enhance the performance of antibodies like Os07g0183200 Antibody . This approach can:

• Enhance Epitope Targeting: RAbD can redesign complementarity-determining regions (CDRs) to improve binding affinity and specificity to Os07g0183200 protein epitopes.

• Optimize Cross-Reactivity: Using the Monte Carlo plus minimization (MCM) procedure, RAbD can modify sequence and structure to refine cross-reactivity profiles for detecting Os07g0183200 homologs across rice varieties .

• Improve Stability: The framework can be used to enhance antibody stability under experimental conditions through targeted sequence modifications based on energy optimization.

• Refine CDR Sampling: RAbD samples antibody sequences and structures by grafting from canonical clusters of CDRs, which could be applied to fine-tune the Os07g0183200 Antibody binding interface .

Researchers can utilize RAbD's flexible-backbone design protocol as a computational pre-screening tool before investing in antibody production or modification, potentially saving time and resources in developing specialized Os07g0183200 detection reagents .

What strategies should be employed to address potential cross-reactivity with other rice proteins?

Cross-reactivity with homologous rice proteins represents a significant challenge when working with Os07g0183200 Antibody. Several methodological approaches can mitigate this concern:

• Sequence Alignment Analysis: Prior to experiments, perform bioinformatic analysis of the Os07g0183200 protein sequence against the rice proteome to identify potential cross-reactive proteins sharing significant sequence homology.

• Pre-adsorption Controls: Pre-incubate the antibody with recombinant potential cross-reactive proteins to assess and eliminate cross-reactivity.

• Multi-technique Verification: Confirm results using alternative detection methods such as mass spectrometry or nucleic acid-based approaches to validate antibody-based findings.

• Knockout/Knockdown Controls: When available, use Os07g0183200 knockout or knockdown rice lines as negative controls to confirm signal specificity.

• Epitope Mapping: Determine the specific epitope recognized by the antibody to better predict potential cross-reactive proteins.

This strategic approach increases confidence in experimental results and addresses a key concern highlighted in the literature regarding antibody specificity and experimental reproducibility .

How should post-translational modifications of Os07g0183200 protein be considered in experimental design?

Post-translational modifications (PTMs) can significantly affect antibody recognition and experimental outcomes. For Os07g0183200 protein studies:

• PTM Prediction Analysis: Utilize bioinformatic tools to predict potential PTM sites on Os07g0183200 protein, focusing on phosphorylation, glycosylation, and ubiquitination.

• Sample Preparation Optimization: Develop protocols that preserve PTMs of interest while removing interfering modifications. This may include phosphatase inhibitors for phosphorylation studies or specific lysis conditions.

• Modified Protein Controls: When possible, use recombinant Os07g0183200 with defined modifications as positive controls.

• Complementary Approaches: Employ modification-specific staining or detection methods alongside antibody-based methods to confirm the presence of specific PTMs.

• PTM-Specific Antibodies: Consider using modification-specific antibodies in conjunction with Os07g0183200 Antibody for co-localization studies to confirm modification status.

This comprehensive approach ensures that experimental design accounts for the dynamic nature of the Os07g0183200 protein and its potential functional modifications in different physiological contexts.

What are the optimal protocols for Western blot analysis using Os07g0183200 Antibody?

Based on the antibody specifications and general best practices for rice plant antibodies, the following Western blot protocol is recommended:

• Sample Preparation:

  • Extract proteins using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail.

  • Quantify protein and load 20-50 μg per lane.

• Gel Electrophoresis and Transfer:

  • Separate proteins on a 10-12% SDS-PAGE gel.

  • Transfer to PVDF membrane (preferred over nitrocellulose for plant proteins).

• Blocking and Antibody Incubation:

  • Block with 5% non-fat milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature.

  • Incubate with Os07g0183200 Antibody at 1:500-1:2000 dilution in blocking buffer overnight at 4°C.

  • Wash 3×10 minutes with TBST.

  • Incubate with HRP-conjugated anti-rabbit secondary antibody at 1:5000 dilution for 1 hour at room temperature.

  • Wash 3×10 minutes with TBST.

• Detection:

  • Develop using ECL substrate and capture images with appropriate documentation system.

  • For weak signals, consider enhanced chemiluminescence substrates or longer exposure times.

This protocol has been optimized based on the antibody's validated applications in Western blot analysis and general practices for plant protein detection.

How should researchers troubleshoot weak or non-specific signals when using Os07g0183200 Antibody?

When encountering issues with Os07g0183200 Antibody performance, systematic troubleshooting should follow this methodological approach:

• Weak Signal Resolution:

  • Increase antibody concentration incrementally (e.g., from 1:1000 to 1:500).

  • Extend primary antibody incubation time (overnight at 4°C).

  • Enhance detection sensitivity using high-sensitivity ECL substrates.

  • Improve protein extraction efficiency with alternative lysis buffers optimized for rice tissues.

  • Concentrate protein samples if target expression is low.

• Non-specific Signal Resolution:

  • Increase blocking stringency (5% to 10% milk or BSA).

  • Add 0.1-0.5% Tween-20 to antibody dilution buffer.

  • Include competitive blocking with rice leaf extract from species not expressing the target.

  • Reduce antibody concentration and incubation time.

  • Perform additional washing steps with increased salt concentration (up to 500 mM NaCl).

• Background Reduction:

  • Pre-adsorb the antibody with rice extract lacking the target protein.

  • Use fresh transfer buffers and blocking reagents.

  • Consider alternative blocking agents (casein, fish gelatin) if milk proteins cause cross-reactivity.

• Control Implementation:

  • Always include positive control (recombinant Os07g0183200 protein) and negative control (non-expressing tissue).

  • Use loading controls appropriate for rice tissue samples (e.g., rice actin or tubulin).

This systematic approach allows for methodical optimization of experimental conditions to achieve specific detection of Os07g0183200 protein.

What considerations are important for adapting Os07g0183200 Antibody for immunohistochemistry applications?

Although the Os07g0183200 Antibody has been primarily validated for ELISA and Western blot applications , researchers may wish to adapt it for immunohistochemistry (IHC). The following methodological considerations are essential:

• Fixation Optimization:

  • Test multiple fixatives (4% paraformaldehyde, Bouin's solution, and glutaraldehyde-based fixatives) to determine optimal epitope preservation.

  • Consider the impact of fixation time on antigen accessibility.

• Antigen Retrieval Assessment:

  • Evaluate heat-induced epitope retrieval methods using citrate buffer (pH 6.0) and Tris-EDTA buffer (pH 9.0).

  • Test enzymatic retrieval using proteinase K or trypsin if heat-based methods are insufficient.

• Dilution Series Testing:

  • Perform a dilution series (1:50 to 1:500) to determine optimal antibody concentration for IHC.

  • Extend incubation times (overnight at 4°C) to enhance sensitivity.

• Signal Amplification Methods:

  • Consider tyramide signal amplification or polymer-based detection systems to increase sensitivity.

  • Evaluate fluorescent secondary antibodies for co-localization studies.

• Background Reduction Strategies:

  • Pre-incubate tissue sections with normal serum from the same species as the secondary antibody.

  • Include 0.1-0.3% Triton X-100 in blocking buffers to reduce non-specific binding.

  • Use avidin-biotin blocking kit if biotin-based detection systems are employed.

These methodological adaptations provide a framework for expanding the utility of Os07g0183200 Antibody beyond its validated applications while maintaining experimental rigor.

How should quantitative data from Os07g0183200 Antibody experiments be analyzed?

Rigorous data analysis is crucial for obtaining reliable quantitative information from Os07g0183200 Antibody experiments. The following methodological approach is recommended:

• Image Acquisition Standards:

  • Capture images using identical exposure settings across all samples and replicates.

  • Include standard curves using recombinant Os07g0183200 protein for absolute quantification.

  • Avoid saturated signals that compromise linearity of measurement.

• Normalization Strategies:

  • Normalize target protein signals to appropriate loading controls (rice actin, tubulin, or GAPDH).

  • For tissue sections, normalize to tissue area or cell count.

  • Consider normalizing to total protein using stain-free technology or Ponceau S staining.

• Statistical Analysis Framework:

  • Use at least three biological replicates and technical duplicates for each experiment.

  • Apply appropriate statistical tests based on data distribution (parametric or non-parametric).

  • Implement ANOVA with post-hoc tests for multiple treatment comparisons.

  • Report effect sizes alongside p-values to indicate biological significance.

• Interpretation Guidelines:

  • Establish detection limits and linear range for quantification.

  • Be cautious interpreting small changes (<1.5-fold) without substantial replication.

  • Consider potential impacts of post-translational modifications on signal intensity.

  • Triangulate findings with complementary methods (qRT-PCR, mass spectrometry).

This systematic analytical approach enhances the reproducibility and reliability of quantitative experiments using Os07g0183200 Antibody, addressing concerns highlighted in the literature about rigor in antibody-based research .

How should contradictory results between antibody-based and nucleic acid-based detection of Os07g0183200 be reconciled?

Discrepancies between protein and mRNA levels of Os07g0183200 are not uncommon and require systematic evaluation. The following methodological approach helps researchers reconcile such contradictions:

• Potential Biological Explanations:

  • Post-transcriptional regulation may affect mRNA translation efficiency.

  • Protein turnover rates can differ significantly from mRNA degradation rates.

  • Alternative splicing may produce protein variants not recognized by the antibody.

  • Post-translational modifications may mask epitopes, affecting antibody recognition.

• Technical Verification Steps:

  • Confirm primer specificity for nucleic acid-based methods using sequencing.

  • Validate antibody specificity using knockout/knockdown controls or epitope blocking.

  • Apply alternative antibodies targeting different epitopes of Os07g0183200.

  • Use absolute quantification standards for both protein and mRNA measurements.

• Integrative Analysis Approach:

  • Perform time-course experiments to detect potential temporal shifts between mRNA and protein expression.

  • Include translation inhibitor experiments to assess protein half-life.

  • Apply ribosome profiling to assess translation efficiency.

  • Implement polysome profiling to evaluate mRNA translation status.

• Comprehensive Reporting:

  • Document all methodological details for both protein and nucleic acid detection.

  • Report contradictory results transparently in publications.

  • Discuss biological implications of discrepancies rather than dismissing them.

This structured approach transforms apparent contradictions into valuable research insights about Os07g0183200 regulation and reinforces the importance of using complementary methods in plant molecular biology research.

What are the current limitations in research applications of Os07g0183200 Antibody?

Understanding the limitations of Os07g0183200 Antibody is essential for proper experimental design and data interpretation. Key limitations include:

• Species Cross-Reactivity Constraints:

  • The antibody has only been validated for Oryza sativa subsp. japonica (Rice) .

  • Cross-reactivity with other Oryza species or subspecies requires validation.

  • Application to distant plant species is not recommended without extensive validation.

• Application Range Restrictions:

  • Currently validated only for ELISA and Western blot applications .

  • Immunohistochemistry, immunoprecipitation, and flow cytometry applications require additional validation.

• Isoform Recognition Limitations:

  • May not detect all splice variants or isoforms of Os07g0183200 protein.

  • Post-translational modifications may affect epitope recognition.

• Production Variability:

  • As a polyclonal antibody, lot-to-lot variation is expected.

  • The made-to-order nature (14-16 week lead time) necessitates advance planning and batch testing.

• Availability Constraints:

  • Limited commercial sources may impact experimental reproducibility across research groups.

  • The extended production time may present challenges for time-sensitive research projects.

Acknowledging these limitations aligns with efforts to enhance reproducibility in antibody-based research and encourages researchers to implement appropriate controls and validation strategies in their experimental design.

How can Os07g0183200 Antibody be incorporated into multiplexed detection systems for rice protein studies?

Multiplexed detection offers greater experimental efficiency and contextual protein information. The following methodological approaches enable multiplexed applications of Os07g0183200 Antibody:

• Spectral Multiplexing Strategies:

  • Utilize secondary antibodies with distinct fluorophores for simultaneous detection of Os07g0183200 and other rice proteins.

  • Implement sequential reprobing protocols with careful antibody stripping between detections.

  • Consider size-based separation coupled with different visualization methods (fluorescent and chemiluminescent).

• Multi-Epitope Detection Systems:

  • Design panel-based approaches where Os07g0183200 Antibody is used alongside antibodies targeting functionally related rice proteins.

  • Optimize antibody dilutions individually before combining in multiplexed formats.

  • Validate for potential cross-interference between different primary-secondary antibody pairs.

• Advanced Platform Integration:

  • Adapt for microarray-based profiling of rice protein expression.

  • Explore compatibility with Bio-Plex or Luminex bead-based multiplexing systems.

  • Consider integration with automated western blotting systems optimized for multiplexing.

• Spatial Context Preservation:

  • Develop protocols for multi-color immunofluorescence in rice tissue sections.

  • Optimize for tissue clearing techniques compatible with rice samples.

  • Evaluate compatibility with imaging mass cytometry for spatial protein profiling.

These approaches expand the experimental utility of Os07g0183200 Antibody while maintaining methodological rigor and specificity in complex detection scenarios.

What are the prospects for applying computational antibody design to enhance Os07g0183200 Antibody specificity?

Computational antibody design represents a frontier for optimizing research reagents like Os07g0183200 Antibody. The following methodological applications of frameworks like RosettaAntibodyDesign (RAbD) show particular promise:

• Epitope-Focused Optimization:

  • Utilize RAbD's capability to redesign CDRs for enhanced binding to specific epitopes of Os07g0183200 protein .

  • Apply structure-based design to reduce cross-reactivity with homologous rice proteins.

  • Implement flexible-backbone design protocols incorporating cluster-based CDR constraints to refine binding interface .

• Stability Enhancement:

  • Apply energy minimization algorithms to improve antibody stability under experimental conditions.

  • Optimize complementarity-determining regions (CDRs) for improved thermal stability while maintaining affinity.

  • Design modifications that enhance expression and purification yields of recombinant antibody fragments.

• Affinity Maturation Simulation:

  • Employ computational algorithms that mimic natural affinity maturation processes.

  • Simulate the impact of specific mutations on binding energy using Monte Carlo plus minimization procedures .

  • Identify high-potential candidates for experimental validation.

• Format Adaptation:

  • Model conversion to alternative antibody formats (scFv, Fab) for specialized applications.

  • Predict structural impacts of humanization for potential therapeutic applications.

  • Design linker optimizations for bifunctional antibody constructs.

The integration of computational approaches with traditional antibody production methods represents a promising direction for developing next-generation Os07g0183200 detection reagents with enhanced specificity, affinity, and versatility .

What are the recommended best practices for ensuring reproducibility in Os07g0183200 Antibody experiments?

To address the broader concerns about antibody reproducibility in research , the following best practices are essential when working with Os07g0183200 Antibody:

• Comprehensive Documentation:

  • Record complete antibody information: catalog number, lot number, concentration, and storage conditions.

  • Document detailed experimental protocols including blocking conditions, antibody dilutions, and incubation times.

  • Maintain a laboratory antibody validation database with performance metrics for each lot.

• Rigorous Validation Framework:

  • Implement a multi-step validation protocol before using new lots.

  • Include appropriate positive and negative controls in every experiment.

  • Verify key findings with complementary techniques not reliant on antibodies.

• Transparency in Reporting:

  • Provide complete antibody information in publications, including validation methods.

  • Include representative images of positive and negative controls.

  • Share detailed protocols via protocols.io or similar platforms.

  • Make validation data available through repositories or supplementary material.

• Strategic Experimental Design:

  • Use biological replicates from independent experiments.

  • Include technical replicates to assess method variability.

  • Design experiments with appropriate statistical power.

  • Implement blinding procedures for analysis when feasible.

By adhering to these methodological best practices, researchers can significantly enhance the reproducibility and reliability of studies utilizing Os07g0183200 Antibody, contributing to more robust rice molecular biology research.